Who we are

MEET SIGMEDD

The name of this organization is the Statistical Interest Group for Medical Devices and Diagnostics (SIGMEDD) of the American Statistical Association, herein after referred to as SIGMEDD.


The objective of SIGMEDD is to promote application and appropriate use of statistics to the design, development, evaluation, quality control and use of medical devices and diagnostic tests in humans. All members of the American Statistical Association who are interested in medical devices and diagnostics are eligible to be members in SIGMEDD.


Officers for Year 2012

Officers-Elect will succeed the current Officers in 2013.

Gregory Campbell

Chair

"I have been working at FDA Center for Devices and Radiological Health (CDRH) since 1995 as the Director of Division of Biostatistics. The Division has taken a lead in helping to organize a number of Topic Contributed sessions at the Joint Statistical Meetings for the past few years and we have watched interest grow in the unique challenges that medical device studies pose to the statistical design and analysis. The establishment of the (Statistical) Interest Group on Medical Devices and Diagnostics (SIGMEDD) was an effort I helped to lead, with a lot of help and interest from statisticians in government, industry and academia. CDRH’s Division of Biostatistics has partnered with statisticians with the trade group AdvaMed to plan a joint meeting in April for the last three or four years where many statistical issues are explored in the design and analysis of clinical studies for therapeutic and diagnostic medical devices.

Moving forward, an early task to be done in December and January will be to provide support and encouragement to the Program Chair and Program Chair-Elect to begin the process of organizing Topic Contributed sessions and other activities (roundtable discussions, etc.) for the JSM 2012 in San Diego. I look forward to working with all the members of the Executive Committee. There will also need to be some advance work to make sure that we have a meeting room for our business meeting in San Diego. A challenge is to continue to make statisticians aware of this Interest Group and its activities. While the current membership is well over 100, I suspect that there is a great deal more interest in industry and academia for the unique statistical issues which studies of medical devices and diagnostic products pose. It may be possible to stir some interest in organizing one or more Invited Sessions for JSM in 2013 (and a Section to serve as Sponsor) and that would need to take place by the summer of 2012. A topic of discussion for the business meeting in San Diego may be whether there is interest within the Interest Group to move toward becoming a recognized Section within ASA. I would anticipate that there would be other activities that the membership might want to have the Interest Group be involved in and I would plan to help facilitate such activities. Towards the end of the 1 year some thought should be given to passing on to the next round of officers some idea of target dates for officers for the next year’s predicted activities."

Scott Berry

Chair-Elect

"For the last 11 years I have been working as a consulting statistician in the medical device and pharmaceutical industry. I have worked for many medical device companies, small and large, in designing innovative, flexible designs that have helped create a new standard of designs in the industry. We continue to create innovative and efficient designs, raising the scientific bar and raising the profile of statistics within the device industry.

In my role as Chair-Elect I would like to focus on three concepts. The first is to raise the profile of statistics within the medical device industry. The second is to push for innovative, scientifically strong, and flexible designs and analyses in medical device applications. Third, is to help build a strong community of statisticians with a focus in the medical device industry.

The role of statisticians in the medical field in general is typically minor. I think we need to be at the table when big decisions are made. Statisticians need to be drivers of designs and decisions. This problem is even worse within the medical device community. Given the industry environment with many small companies, there are many companies that don’t have professional statisticians. Many statisticians in the industry play minor roles of data management and routine analyses. There is a great opportunity and need for statisticians in the medical device industry. The industry is unique, providing many opportunities for innovation and leadership and many of these differences highlight important statistical concepts. There is an enormous need and opportunity for statisticians to lead.

In order for statisticians to be leaders in this industry it demands we lead by example. We must be innovators, we must help create good solutions, while maintaining high scientific standards—we must perform.

In order to become leaders and innovators in the medical device industry we need to provide a strong group of statisticians. The SIGMEDD group can provide a great structure to share ideas, create innovation as an industry, and provide opportunities to raise the profile of the statistics profession within the device industry."

Brian Wiens

Program Chair

"I am involved in design, analysis and interpretation of clinical trials to support regulatory approval and commercialization of devices in ophthalmology. Primarily these are implantable lenses for use after cataract extraction surgery and surgical instruments used for various surgical procedures, along with some OTC consumer care products which are regulated as devices. These devices are approved in the United States through the PMA or 510(k) process and in other countries via the CE Mark process.

The role for the program chair is to develop the technical program at statistics meetings. A good technical program requires a program chair who will seek out interesting topics and compelling speakers to form an exciting program. The program chair must also understand the rules and processes around the technical sessions to ensure the sessions are accepted. While JSM is an important venue and will receive my attention, smaller meetings will be of interest as well. The annual FDA-Industry Statistics Workshop is an example of a meeting at which SIGMEDD can have high visibility, in cooperation with the Workshop organizing committee. A presence on the technical program at other meetings, such as the ENAR Spring Meeting, is important to increase our visibility to students and others who are considering career paths but who are not familiar with medical devices and diagnostics.

Program chairs have other responsibilities than organizing technical programs at meetings. The officers of SIGMEDD, including the program chair, are important for conducting the business of the interest group. Such activities include membership retention and expansion, liaising with the ASA office, discussing areas of common interest with sections (notably the Biopharmaceutical Section) and potentially undertaking joint projects with other organizations or sections."

Lilly Yue

Program Chair-Elect

"As the Deputy Division Director for Premarket and Operations in the Division of Biostatistics (DBS) of FDA’s Center for Devices and Radiological Health (CDRH), I oversee the pre-market statistical reviews of therapeutic, aesthetic and diagnostic device submissions. I understand not only the critical issues in the application of statistics to medical device and diagnostic clinical studies, but also the issues of mutual interest among industry, academia, and government statisticians.

I would continue to work closely with statisticians from industry, academia and the FDA and enhance the collaboration. For example, as the FDA Co-Chair of FDA/Industry Statistics Workshop 2013, I would strive to increase the visibility of SIGMEDD and the involvement of statisticians from the medical devices and diagnostics. Within the FDA, I would drive to increase the transparency and predictability of regulatory pre-market statistical reviews, and promote the application of novel statistical methods and the appropriate use of statistics."

Jeng Mah

Communications Secretary

"I have been working on medical device and diagnostic studies for over 15 years. I am a strong supporter in recognizing the differences between medical device and pharmaceutical studies and in developing appropriate and efficient statistical methods in the evaluation of devices and diagnostic methods. I have developed and maintained the SIGMEDD website since 2008 in order to help foster and facilitate communication among statisticians and other professional groups. "

Gene Pennello

Correspondence Secretary

"My current position at FDA is Mathematical Statistician and Team Leader, Diagnostic Devices Branch, Division of Biostatistics, Center for Devices and Radiological Health, Food and Drug Administration (2005-present). Prior to 2005, I was an FDA reviewer for many therapeutic devices, including cardiovascular and other implantable devices. I was originally hired by FDA to help with an initiative for Bayesian medical device clinical trials, and continue to contribute in this area. I have some experience with statistical data mining tools for finding post-market signals of safety events associated with devices. My experience with diagnostic devices includes in vitro diagnostic tests, diagnostic imaging, pharmacogenomics, prognostic biomarkers, and companion diagnostics. My other interests include multiple comparisons, missing data, and epidemiology. Prior to FDA, I was a postdoctoral training fellow at the Division of Cancer Epidemiology and Genetics, National Cancer Institute (1994-1998).

I’ll do my best to produce minutes at SIGMEDD Business meetings that reflect what transpired at the meetings. I’ll post the minutes promptly at the SIGMEDD website."